Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0114080002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02520001 | GRIFOLS THERAPEUTICS LLC | HYPERHEP B | Human | Yes | Schedule D | 1 | HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 220 UNIT / ML |
Marketed | 02520125 | GRIFOLS THERAPEUTICS LLC | HYPERHEP B | Human | No | Schedule D | 1 | HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 110 UNIT / 0.5 ML |
Approved | 02520133 | GRIFOLS THERAPEUTICS LLC | HYPERHEP B | Human | Yes | Schedule D | 1 | HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 220 UNIT / ML |
Cancelled Post Market | 02230738 | GRIFOLS THERAPEUTICS LLC | HYPERHEP B S/D | Human | Yes | Schedule D | 1 | HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 220 UNIT / ML |
Cancelled Post Market | 02379465 | GRIFOLS THERAPEUTICS LLC | HYPERHEP B S/D | Human | Yes | Schedule D | 1 | HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 220 UNIT / ML |
Cancelled Pre Market | 02379473 | GRIFOLS THERAPEUTICS LLC | HYPERHEP B S/D | Human | Yes | Schedule D | 1 | HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 220 UNIT / ML |
Application information
Related information
Contact us
Version 4.0.3